<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Vestibular schwannoma international study of active surveillance versus stereotactic radiosurgery: the VISAS study

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Bin-Alamer, Othman

Abou-Al-Shaar, Hussam

Pelcher, Isabelle

Begley, Sabrina

Goenka, Anuj

Schulder, Michael

Tourigny, Jean-Nicolas

Mathieu, David

Hamel, Andréanne

Briggs, Robert G

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Purpose: The present study assesses the safety and efficacy fi cacy of stereotactic radiosurgery (SRS) versus observation for Koos grade 1 and 2 vestibular schwannoma (VS), benign tumors affecting hearing and neurological function. Methods and Materials: This multicenter study analyzed data from Koos grade 1 and 2 VS patients managed with SRS (SRS group) or observation (observation group). Propensity score matching balanced patient demographics, tumor volume, and audiometry. Outcomes measured were tumor control, serviceable hearing preservation, and neurological outcomes. Results: In 125 matched patients in each group with a 36-month median follow-up (P = .49), SRS yielded superior 5- and 10- year tumor control rates (99% CI, 97.1%-100%, and 91.9% CI, 79.4%-100%) versus observation (45.8% CI, 36.8%-57.2%, and 22% CI, 13.2%-36.7%; P < .001). Serviceable hearing preservation rates at 5 and 9 years were comparable (SRS 60.4% CI, 49.9%-73%, vs observation 51.4% CI, 41.3%-63.9%, and SRS 27% CI, 14.5%-50.5%, vs observation 30% CI, 17.2%-52.2%; P = .53). SRS were associated with lower odds of tinnitus (OR = 0.39, P = .01), vestibular dysfunction (OR = 0.11, P = .004), and any cranial nerve palsy (OR = 0.36, P = .003), with no change in cranial nerves 5 or 7 (P> > .05). Composite endpoints of study tumor progression and/or any of the previous outcomes showed significant fi cant lower odds associated with SRS compared with observation alone (P < .001). Conclusions: SRS management in matched cohorts of Koos grade 1 and 2 VS patients demonstrated superior tumor control, comparable hearing preservation rates, and significantly fi cantly lower odds of experiencing neurological deficits. fi cits. These fi ndings delineate the safety and efficacy fi cacy of SRS in the management of this patient population.

Source

Publisher

Elsevier

Citation

item.page.haspartof

Source

International Journal of Radiation Oncology Biology Physics

item.page.ispartofseries

item.page.edition

DOI

10.1016/j.ijrobp.2024.04.004

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators